Gout as a cardiovascular risk factor

被引:0
作者
Hernandez Batista, Sulema de la Caridad [1 ]
Villafuerte Morales, Johanna Elizabeth [1 ]
Chimbolema Mullo, Sergio Orlando [2 ]
Pilamunga Lema, Cesar Lenin [1 ]
机构
[1] Escuela Super Politecn Chimborazo, Riobamba, Chimborazo, Ecuador
[2] Univ Nacl Chimborazo, Riobamba, Chimborazo, Ecuador
来源
REVISTA CUBANA DE REUMATOLOGIA | 2021年 / 23卷 / 03期
关键词
cardiovascular disease; rheumatic disease; gout; arterial hypertension;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Gout is a chronic inflammatory disease that generally progresses with added hyperuricemia. Objective: To identify the presence of cardiovascular involvement in patients with a confirmed diagnosis of gouty arthropathy. Methodology: A basic, non-experimental, descriptive, retrospective and mixed-focus research was developed. The universe consisted of 69 patients treated in first-level health care units in the city of Riobamba during the period between January 2019 and January 2021. The sample was made up of a total of 60 patients. A review of the clinical history of the patients was carried out to obtain the necessary information. Result: Average age of 53.02 years. 35.00% of them presented at least one associated comorbidity, where diabetes mellitus was the most represented (57.14%). with presence of comorbidities. 71.67% of the patients had normal blood uric acid values at the time of diagnosis and 18.33% had some type of kidney damage. 36.67% of the patients with gout also presented cardiovascular disease, where arterial hypertension (59.09% was the most frequently reported. Conclusions: Gouty arthropathy is a disease that theoretically generates a high percentage of cardiovascular diseases within of which arterial hypertension and heart failure stand out.
引用
收藏
页数:10
相关论文
共 13 条
  • [1] Parreño ICC, 2019, REV CUBA REUMATOL, V21
  • [2] Leal Balon E, 2020, ARCH HOSP U GEN CALI, V8
  • [3] Lombas Garcia M, 2009, REV CUBANA MED, V13
  • [4] López-Rocha Eunice Giselle, 2018, Rev. alerg. Méx., V65, P316, DOI 10.29262/ram.v65i3.369
  • [5] Machado Curbelo AJ, 2020, REV CUBANA MED, V16
  • [6] Maria Ortiz Olivares Ana, 2019, MEDISAN, V23, P114
  • [7] Santillana-Marin RA, 2020, REV MEX ING BIOMED, V39, P262
  • [8] Solis Cartas U, 2018, REV CUBA REUMATOL, V20, pe14
  • [9] Valdes Gonzalez JL, 2020, REV CUBANA REUMATOLO, V22
  • [10] González JLV, 2020, REV CUBA REUMATOL, V22